Michael Egholm - Net Worth and Insider Trading

Michael Egholm Net Worth

The estimated net worth of Michael Egholm is at least $2 Million dollars as of 2026-09-11. Michael Egholm is the President & CEO of Standard BioTools Inc and owns about 2,741,191 shares of Standard BioTools Inc (LAB) stock worth over $2 Million. Details can be seen in Michael Egholm's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael Egholm has not made any transactions after 2025-05-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Michael Egholm

To

Are these stocks worth buying? — GuruFocus analysis for each holding

Michael Egholm Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael Egholm owns 2 companies in total, including Standard BioTools Inc (LAB) , and IsoPlexis Corp (ISO) .

Click here to see the complete history of Michael Egholm’s form 4 insider trades.

Insider Ownership Summary of Michael Egholm

Ticker Company Transaction Date Type of Owner
LAB Standard BioTools Inc 2025-05-23 director & President & CEO
ISO IsoPlexis Corp 2022-06-16 director

Michael Egholm Latest Holdings Summary

Michael Egholm currently owns a total of 1 stock. Michael Egholm owns 2,741,191 shares of Standard BioTools Inc (LAB) as of May 23, 2025, with a value of $2 Million.

Latest Holdings of Michael Egholm

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
LAB Standard BioTools Inc 2025-05-23 2,741,191 0.69 1,883,746

Holding Weightings of Michael Egholm


Michael Egholm Form 4 Trading Tracker

According to the SEC Form 4 filings, Michael Egholm has made a total of 3 transactions in Standard BioTools Inc (LAB) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Standard BioTools Inc is the sale of 5,473 shares on May 23, 2025, which brought Michael Egholm around $5,145.

Insider Trading History of Michael Egholm

* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Michael Egholm Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Get the full picture on these stocks
See GF Score, valuation, financials, and warning signs for every stock Michael Egholm owns.
View LAB Analysis

Michael Egholm Ownership Network

Ownership Network List of Michael Egholm

No Data

Ownership Network Relation of Michael Egholm

Insider Network Chart


Michael Egholm Owned Company Details

What does Standard BioTools Inc do?

Who are the key executives at Standard BioTools Inc?

Michael Egholm is the director & President & CEO of Standard BioTools Inc. Other key executives at Standard BioTools Inc include director & 10 percent owner Casdin Partners Master Fund, L.p. , Chief Operating Officer Hanjoon Alex Kim , and SVP & Chief Business Officer Sean Mackay .

Standard BioTools Inc (LAB) Insider Trades Summary

Over the past 18 months, Michael Egholm made 3 insider transaction in Standard BioTools Inc (LAB) with a net sale of 15,308. Other recent insider transactions involving Standard BioTools Inc (LAB) include a net purchase of 12,708,220 shares made by Casdin Partners Master Fund, L.p. , a net sale of 4,190 shares made by Hanjoon Alex Kim , and a net sale of 38,591 shares made by Sean Mackay .

In summary, during the past 3 months, insiders sold 0 shares of Standard BioTools Inc (LAB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 58,089 shares of Standard BioTools Inc (LAB) were sold and 12,708,220 shares were bought by its insiders, resulting in a net purchase of 12,650,131 shares.

Standard BioTools Inc (LAB)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Standard BioTools Inc Insider Transactions

No Available Data

Michael Egholm Mailing Address

Above is the net worth, insider trading, and ownership report for Michael Egholm. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Michael Egholm's mailing address is: South San Francisco Ca 94080.